Pharmaceutical Industry Information Portal

HomeNews

News

Contract production of pharmaceutical ingredients by 2028 may reach $ 136 billion

The traditional active pharmaceutical ingredient dominated the market and accounted for the largest revenue share of 40.5% in 2020.

FDA warns of clinical trial results showing increased risk of death associated with Pepaxto

Due to the detrimental effect on overall survival in the OCEAN trial, FDA is requiring the manufacturer suspend enrollment in the trial.

ICH releases widely anticipated guidance on continuous manufacturing

Three different models of continuous manufacturing are described in the draft guideline. The guideline incorporates the ICH Q7 definition of a batch to continuous manufacturing.

Amgen To Acquire Privately Held Teneobio For $900 Million

The acquisition includes Teneobio's proprietary bispecific and multispecific antibody technologies, which will enable significant acceleration and efficiency in the discovery and development of new molecules.

AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity

AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed against the GPR75 target with the potential...

STADA and Sanofi strike consumer healthcare distribution agreement in selected countries in Europe

The agreement covers approximately 50 well-established consumer healthcare brands currently marketed by Sanofi.
spot_img

Expert Articles

spot_img